Applications of Polymers in Intraocular Drug Delivery Systems
Journal Title: International Journal of Ophthalmology & Eye Science (IJOES) - Year 2015, Vol 0, Issue 8
Abstract
We are entering a new era of ophthalmic pharmacology where new drugs are rapidly being developed for the treatment of anterior and posterior-segment of the eye disease. The pharmacokinetics of drug delivery to the eye remains a very active area of ophthalmic research. Intraocular drug delivery systems allow the release of the drug, bypassing the blood-ocular barrier. The main advantage of these preparations is that they can release the drug over a long time with one single administration. These pharmaceutical systems are of great important in the treatment of posterior segment diseases, and they can be prepared from biodegradable or non-biodegradable polymers. Biodegradable polymers have the advantage of disappearing from the site of action after releasing the drug. The majority of intraocular devices are prepared from non-biodegradable polymers, and they can release controlled amounts of drugs for months. Non-biodegradable polymers include silicone, polyvinyl alcohol (PVA) and ethylvinylacetate (EVA). The polymers usually employed to prepare nanoparticles for the topical ophthalmic route are poly (acrylic acid) derivatives (polyalquilcyanocrylates), albumin, poly-ε-caprolactone, and chitosan. Dendrimers are a recent class of polymeric materials with unique nanostructure which has been studied to discover their role in the delivery of therapeutics and imaging agents. Hydrogels are polymers that can swell in aqueous solvent system, and they hold the solvents in a swollen crosslinked gel for delivery. This review exhibits the current literature regarding applications of polymers in ophthalmic drug delivery systemsincluding pharmacokinetics, advantages, disadvantages and indications aimed to obtain successful eye therapy.
Authors and Affiliations
Ali M Al-Halaf
Keywords
Related Articles
- EP ID EP200128
- DOI 10.19070/2332-290X-SI05001
- Views 81
- Downloads 0
Central Retinal Artery Occlusion during Cisplatin and Etoposide Chemotherapy for Small Cell Lung Cancer
We present our findings in a case of central retinal artery occlusion (CRAO) that developed in a patient while being treated with intravenous cisplatin (CDDP) and etoposide (VP16) for small cell lung cancer. The patient...
Retinal Pigment Epithelial Cell Line Suppression of Phagolysosome Activation
The eye is an immune privileged tissue with multiple mechanisms of immunosuppression to protect the light gathering tissues from the damage of inflammation. One of theses mechanisms involves retinal pigment epithelial ce...
Applications of Polymers in Intraocular Drug Delivery Systems
We are entering a new era of ophthalmic pharmacology where new drugs are rapidly being developed for the treatment of anterior and posterior-segment of the eye disease. The pharmacokinetics of drug delivery to the eye re...
Photoacoustic Imaging in Ophthalmology
Photoacoustic (PA) imaging is a rapidly developing new biomedical imaging modality. Unlike existing ophthalmic imaging technology such as fundus photography, optical coherence tomography, fluorescein and indocyanine gree...
Modified Osteo Odonto Keratoprosthesis (MOOKP) - "Tooth For An Eye"
Osteo-odonto-keratoprosthesis (OOKP) (also known as "tooth in eye" surgery is a medical procedure to restore vision in the most severe cases of corneal and ocular surface patients. It includes removal of a tooth from the...